http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022098544-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db72781338b7c026a276f17294405c4f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
filingDate | 2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248f0655321222fc34d84e838dc3c5c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4dfa5921f8ddd798a5e813617cdc5f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dc1d9f1f75be17ca5af8ed36a9ada4a |
publicationDate | 2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2022098544-A1 |
titleOfInvention | Compounds and methods for the targeted degradation of androgen receptor and associated methods of use |
abstract | Bifunctional compounds, which find utility as modulators of androgen receptor (AR), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds AR, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023066350-A1 |
priorityDate | 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 988.